Colorectal cancer trials in China

In China 616 Also abroad 1941

616 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM
Where
Wuhan
Age
18 years to 75 years
People
60
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07728019
Phase 2Taking people
Local Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma After Low Anterior Resection for Rectal Cancer
Where
Beijing
Age
18 years and over
People
26
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07833319
Phase 3Taking people
Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
Where
Shanghai
Age
18 years to 75 years
People
196
Run by
Fudan University
See details and how to joinNCT07132463
No phaseTaking people
Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation
Where
Hefei
Age
18 years to 80 years
People
205
Run by
Anhui Provincial Hospital
See details and how to joinNCT07830576
Phase 1/2Taking people
Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Where
Hangzhou
Age
18 years and over
People
120 worldwide
Run by
Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT07435038
No phaseTaking people
Precision Navigation to Improve Community Cancer Screening Participation
Where
Huaihua, Shaoyang, Yongzhou
Age
45 years to 74 years
People
1,500
Run by
Hunan Cancer Hospital
See details and how to joinNCT07676383
Phase 2Taking people
Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical Trial
Where
Guangzhou
Age
18 years to 75 years
People
84
Run by
Sun Yat-sen University
See details and how to joinNCT07622771
No phaseNot yet taking people in China
Effectiveness of Artificial Intelligence-Assisted Colonoscopy for Adenoma Detection in Routine Clinical Practice : a Prospective Multicenter Randomized Trial
Where
Hangzhou
Age
40 years to 74 years
People
3,300
Run by
Zhejiang University
See details and how to joinNCT07307547
No phaseTaking people
Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
Where
Beijing, Chengdu, Shanghai
Age
18 years to 75 years
People
1,384
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06146946
No phaseTaking people
Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer
Where
Xicheng
Age
18 years and over
People
50
Run by
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
See details and how to joinNCT07333053
No phaseTaking people
HDR Endorectal Brachytherapy With 3D-Printed Guidance and Local Shielding for Rectal Cancer Organ Preservation
Where
Tianjin
Age
18 years to 80 years
People
50
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07786493
Phase 2Not yet taking people in China
Retlirafusp Alfa Plus Targeted Therapy and Chemotherapy for Unresectable Colorectal Liver-Limited Metastases
Where
Beijing
Age
18 years to 79 years
People
80
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07815288
Phase 3Taking people
A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal Cancer
Where
Beijing
Age
18 years to 75 years
People
300
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07676162
Phase 3Taking people
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Where
Beijing
Age
18 years to 70 years
People
165
Run by
Shanghai Kechow Pharma, Inc.
See details and how to joinNCT06008119
Phase 2Taking people
Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer Patients
Where
Guangzhou
Age
18 years to 70 years
People
45
Run by
Sun Yat-sen University
See details and how to joinNCT07809893
Phase 2Not yet taking people in China
Total Neoadjuvant mFOLFOX6 Plus Suvemcitug and Enlonstobart With Selective Omission of Pelvic Radiotherapy for High-Risk Mid-Rectal Locally Advanced Rectal Cancer
Where
Shanghai
Age
18 years to 75 years
People
52
Run by
Fudan University
See details and how to joinNCT07810114
Phase 1/2Taking people
A Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer
Where
Beijing
Age
18 years to 75 years
People
220
Run by
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07805551
No phaseTaking people
Remimazolam for Postoperative Sleep in Elderly Patients
Where
Yinchuan
Age
65 years to 80 years
People
84
Run by
General Hospital of Ningxia Medical University
See details and how to joinNCT07740343
No phaseTaking people
Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma
Where
Shanghai
Age
18 years to 75 years
People
392
Run by
Ruijin Hospital
See details and how to joinNCT07795528
Phase 2Not yet taking people in China
A Single-Arm, Phase II Study of Retlirafusp Alfa in Combination With XELOX and Bevacizumab for the First-Line Treatment of Advanced RAS-Mutated Colorectal Cancer With Liver Metastases (CRLM)
Where
Beijing
Age
18 years to 75 years
People
46
Run by
Dai, Guanghai
See details and how to joinNCT07797244
Phase 1Taking people
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
Where
Beijing, Chengdu, Hangzhou, Jinan, Nanchang, Tianjin
Age
18 years to 75 years
People
96
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05262491
Phase 2Taking people
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Where
Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Jinan, Luoyang, Nanning, Qingdao, Shanghai, Shengyang, Tianjin, Wuhan
Age
18 years to 80 years
People
180
Run by
Multitude Therapeutics Inc.
See details and how to joinNCT07474727
Phase 3Not yet taking people in China
A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan
Where
Shanghai, Shenyang
Age
18 years to 75 years
People
130
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07730489
Phase 2Taking people
A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable Metastases
Where
Hangzhou
Age
18 years to 75 years
People
25
Run by
Zhejiang University
See details and how to joinNCT07789210
Phase 1/2Taking people
HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
Where
Beijing
Age
18 years and over
People
180
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07790510